These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 843724)

  • 1. Inhibition of substance P release from the isolated rat substantia nigra by GABA [proceedings].
    Jessell TM; Iversen LL
    Br J Pharmacol; 1977 Mar; 59(3):486P. PubMed ID: 843724
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulation of GABA release by dopamine in the rat substantia nigra.
    Reubi JC; Iversen LL; Jessell TM
    Adv Biochem Psychopharmacol; 1978; 19():401-4. PubMed ID: 696468
    [No Abstract]   [Full Text] [Related]  

  • 3. The behavioural effects of EOS-induced changes in substantia nigra GABA levels [proceedings].
    Koob G; del Fiacco M; Iversen SD
    Br J Pharmacol; 1976 Nov; 58(3):454P. PubMed ID: 990632
    [No Abstract]   [Full Text] [Related]  

  • 4. Substance P release from the rat substantia nigra.
    Jessell TM
    Brain Res; 1978 Aug; 151(3):469-78. PubMed ID: 667625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A behavioural model of the GABA-facilitating action of benzodiazepines: rotational behaviour after unilateral intranigral injection of chloridiazepoxide [proceedings].
    Waddington JL; Crow TJ
    Br J Pharmacol; 1976 Nov; 58(3):453P. PubMed ID: 990631
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of GABA and L-glutamic acid on the potassium-evoked in vitro release of substance P- and neurokinin A-like immunoreactivities are different in the rat striatum and substantia nigra.
    Humpel C; Saria A
    Neurosci Lett; 1989 Oct; 105(1-2):159-63. PubMed ID: 2484728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation of gamma-aminobutyric acid (GABA) action by inhibiting neuroglial uptake [proceedings].
    Galvan M; Brown DA
    Br J Pharmacol; 1977 Mar; 59(3):485P-486P. PubMed ID: 843723
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of dopaminergic activity in the extrapyramidal and limbic systems by gamma-acetylenic GABA [proceedings].
    Huot S; Lippert B; Palfreyman MG; Schechter PJ
    Br J Pharmacol; 1977 Jun; 60(2):264P-265P. PubMed ID: 880435
    [No Abstract]   [Full Text] [Related]  

  • 9. Synaptosomal uptake and release of dopamine in substantia nigra: effects of gamma-aminobutyric acid and substance P.
    Silbergeld EK; Walters JR
    Neurosci Lett; 1979 Apr; 12(1):119-26. PubMed ID: 460694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo release of endogenous GABA from rat substantia nigra measured by a novel method.
    Van der Heyden JA; Venema K; Korf J
    J Neurochem; 1979 Feb; 32(2):469-76. PubMed ID: 762559
    [No Abstract]   [Full Text] [Related]  

  • 11. Proceedings: Topographical study of the distribution of GABA in the human substantia nigra.
    Kanazawa I; Kelly JS
    Br J Pharmacol; 1975 Oct; 55(2):309P. PubMed ID: 1201435
    [No Abstract]   [Full Text] [Related]  

  • 12. Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra.
    Yamamoto BK; Nash JF; Gudelsky GA
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1063-70. PubMed ID: 7791076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GABAergic mechanisms in regulating the activity state of substantia nigra pars reticulata neurons.
    Windels F; Kiyatkin EA
    Neuroscience; 2006 Jul; 140(4):1289-99. PubMed ID: 16713116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GABA(B) receptor activation inhibits dopamine D1 receptor-mediated facilitation of [(3)H]GABA release in substantia nigra pars reticulata.
    Nava-Asbell C; Paz-Bermudez F; Erlij D; Aceves J; Florán B
    Neuropharmacology; 2007 Oct; 53(5):631-7. PubMed ID: 17868750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progabide reverses the nigral substance P reduction induced by chronic impairment of dopaminergic transmission.
    Zivkovic B; Oblin A; Bartholini G
    Eur J Pharmacol; 1985 Jun; 112(2):253-5. PubMed ID: 2411575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GABA inhibition of 3H-glycine release from slices of rat substantia nigra in vitro.
    Kerwin R; Pycock C
    Eur J Pharmacol; 1980 Jun; 64(2-3):169-72. PubMed ID: 7398760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine selectively increases 3H-GABA release from slices of rat substantia nigra in vitro.
    Reubi JC; Iversen LL; Jessell TM
    Nature; 1977 Aug; 268(5621):652-4. PubMed ID: 197423
    [No Abstract]   [Full Text] [Related]  

  • 18. Changes of amino acid and monoamine levels after neonatal 6-hydroxydopamine denervation in rat basal ganglia, substantia nigra, and Raphe nuclei.
    Molina-Holgado E; Dewar KM; Grondin L; van Gelder NM; Reader TA
    J Neurosci Res; 1993 Jul; 35(4):409-18. PubMed ID: 8360949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GABA-potentiating action of pentobarbitone on the isolated superior cervical ganglion of the rat [proceedings].
    Evans RH
    J Physiol; 1977 Oct; 272(1):49P-50P. PubMed ID: 592147
    [No Abstract]   [Full Text] [Related]  

  • 20. Modulation of GABA release by dopamine in the substantia nigra.
    Matuszewich L; Yamamoto BK
    Synapse; 1999 Apr; 32(1):29-36. PubMed ID: 10188635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.